SG11201405055TA - Pyridinyl and pyrimidinyl sulfoxide and sulfone derivatives - Google Patents
Pyridinyl and pyrimidinyl sulfoxide and sulfone derivativesInfo
- Publication number
- SG11201405055TA SG11201405055TA SG11201405055TA SG11201405055TA SG11201405055TA SG 11201405055T A SG11201405055T A SG 11201405055TA SG 11201405055T A SG11201405055T A SG 11201405055TA SG 11201405055T A SG11201405055T A SG 11201405055TA SG 11201405055T A SG11201405055T A SG 11201405055TA
- Authority
- SG
- Singapore
- Prior art keywords
- pyridinyl
- sulfone derivatives
- pyrimidinyl
- sulfoxide
- pyrimidinyl sulfoxide
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2012071872 | 2012-03-02 | ||
PCT/CN2013/000214 WO2013127267A1 (en) | 2012-03-02 | 2013-03-01 | Pyridinyl and pyrimidinyl sulfoxide and sulfone derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201405055TA true SG11201405055TA (en) | 2014-09-26 |
Family
ID=49081601
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201405055TA SG11201405055TA (en) | 2012-03-02 | 2013-03-01 | Pyridinyl and pyrimidinyl sulfoxide and sulfone derivatives |
Country Status (9)
Country | Link |
---|---|
US (2) | US9458172B2 (en) |
EP (1) | EP2820017B1 (en) |
JP (1) | JP2015508785A (en) |
CN (1) | CN104507936A (en) |
AU (1) | AU2013225531A1 (en) |
CA (1) | CA2865517A1 (en) |
ES (1) | ES2620612T3 (en) |
SG (1) | SG11201405055TA (en) |
WO (1) | WO2013127267A1 (en) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2611804A1 (en) | 2010-09-03 | 2013-07-10 | Forma TM, LLC. | Novel compounds and compositions for the inhibition of nampt |
JP6038792B2 (en) | 2010-09-03 | 2016-12-07 | フォーマ ティーエム, エルエルシー. | 4-{[((Pyridin-3-yl-methyl) aminocarbonyl] amino} benzene-sulfone derivatives as NAMPT inhibitors for the treatment of diseases such as cancer |
CA2834745A1 (en) | 2011-05-09 | 2012-11-15 | Forma Tm, Llc | Piperidine derivatives and compositions for the inhibition of nicotinamide phosphoribosyltransferase (nampt) |
CN104603134A (en) | 2012-03-02 | 2015-05-06 | 基因科技股份有限公司 | Amido-benzyl sulfone and sulfoxide derivatives |
ES2620668T3 (en) | 2012-03-02 | 2017-06-29 | Genentech, Inc. | Spirocyclic amido and sulfonamide derivatives |
JP2015516435A (en) * | 2012-05-11 | 2015-06-11 | アッヴィ・インコーポレイテッド | NAMPT inhibitor |
JP6186440B2 (en) | 2012-09-19 | 2017-08-23 | ノバルティス アーゲー | Dihydropyrrolidinopyrimidines as kinase inhibitors |
JP6510556B2 (en) | 2014-04-18 | 2019-05-08 | ミレニアム ファーマシューティカルズ, インコーポレイテッドMillennium Pharmaceuticals, Inc. | Quinoxaline compounds and uses thereof |
JP2018502141A (en) | 2015-01-20 | 2018-01-25 | ミレニアム ファーマシューティカルズ, インコーポレイテッドMillennium Pharmaceuticals, Inc. | Quinazoline and quinoline compounds and uses thereof |
MX2018001363A (en) | 2015-08-05 | 2018-11-29 | Metro Int Biotech Llc | Nicotinamide mononucleotide derivatives and their uses. |
GB2542881B (en) | 2015-10-02 | 2020-01-01 | Carr Andrew | Crystal forms of ß-nicotinamide mononucleotide |
WO2018086703A1 (en) | 2016-11-11 | 2018-05-17 | Bayer Pharma Aktiengesellschaft | Dihydropyridazinones substituted with phenylureas |
US11180521B2 (en) | 2018-01-30 | 2021-11-23 | Metro International Biotech, Llc | Nicotinamide riboside analogs, pharmaceutical compositions, and uses thereof |
US11939348B2 (en) | 2019-03-22 | 2024-03-26 | Metro International Biotech, Llc | Compositions comprising a phosphorus derivative of nicotinamide riboside and methods for modulation of nicotinamide adenine dinucleotide |
US10618927B1 (en) | 2019-03-22 | 2020-04-14 | Metro International Biotech, Llc | Compositions and methods for modulation of nicotinamide adenine dinucleotide |
CN111943916B (en) * | 2020-09-23 | 2022-03-29 | 济南悟通生物科技有限公司 | Preparation method of 2-methyltetrahydrofuran-3-thiol |
CN112778212B (en) * | 2021-01-28 | 2022-03-15 | 苏州莱克施德药业有限公司 | Synthesis method of cropanisin intermediate 2-aminopyrimidine-5-methyl carboxylate |
BR112023024712A2 (en) | 2021-05-27 | 2024-02-15 | Metro Int Biotech Llc | CRYSTALLINE SOLIDS OF NICOTINE ACID MONONUCLEOTIDE AND ESTERS THEREOF AND METHODS OF MANUFACTURING AND USE |
CN114181276A (en) * | 2021-12-17 | 2022-03-15 | 安徽大学 | Thioester peptide synthesis method |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5380718A (en) * | 1990-05-15 | 1995-01-10 | E. I. Du Pont De Nemours And Company | Arthropodicidal fused tetrahydropyridazines |
US5543523A (en) | 1994-11-15 | 1996-08-06 | Regents Of The University Of Minnesota | Method and intermediates for the synthesis of korupensamines |
WO2005014554A1 (en) | 2003-08-08 | 2005-02-17 | Astex Therapeutics Limited | 1h-indazole-3-carboxamide compounds as mapkap kinase modulators |
TW200700392A (en) * | 2005-03-16 | 2007-01-01 | Astrazeneca Ab | Novel compounds |
JP2010513519A (en) * | 2006-12-22 | 2010-04-30 | ミレニアム・ファーマシューティカルズ・インコーポレイテッド | Certain pyrazoline derivatives with kinase inhibitor activity |
PE20110854A1 (en) * | 2008-09-26 | 2011-12-23 | Boehringer Ingelheim Int | DERIVATIVES OF 1-PHENYL-1H-PYRAZOLO [3,4-c] PYRIDINE-4-CARBONYLAMINE AS ANTAGONISTS OF CCR1 RECEPTORS |
EP3632899A1 (en) * | 2009-05-29 | 2020-04-08 | RaQualia Pharma Inc. | Aryl substituted carboxamide derivatives as calcium or sodium channel blockers |
EP2611804A1 (en) | 2010-09-03 | 2013-07-10 | Forma TM, LLC. | Novel compounds and compositions for the inhibition of nampt |
WO2012061926A1 (en) * | 2010-11-08 | 2012-05-18 | Zalicus Pharmaceuticals Ltd. | Bisarylsulfone and dialkylarylsulfone compounds as calcium channel blockers |
-
2013
- 2013-03-01 AU AU2013225531A patent/AU2013225531A1/en not_active Abandoned
- 2013-03-01 JP JP2014559064A patent/JP2015508785A/en active Pending
- 2013-03-01 CN CN201380022895.2A patent/CN104507936A/en active Pending
- 2013-03-01 ES ES13754209.8T patent/ES2620612T3/en active Active
- 2013-03-01 WO PCT/CN2013/000214 patent/WO2013127267A1/en active Application Filing
- 2013-03-01 EP EP13754209.8A patent/EP2820017B1/en active Active
- 2013-03-01 CA CA2865517A patent/CA2865517A1/en not_active Abandoned
- 2013-03-01 US US14/382,123 patent/US9458172B2/en active Active
- 2013-03-01 SG SG11201405055TA patent/SG11201405055TA/en unknown
-
2016
- 2016-08-22 US US15/243,289 patent/US20160355514A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AU2013225531A1 (en) | 2014-09-25 |
US9458172B2 (en) | 2016-10-04 |
US20160355514A1 (en) | 2016-12-08 |
ES2620612T3 (en) | 2017-06-29 |
WO2013127267A1 (en) | 2013-09-06 |
EP2820017B1 (en) | 2016-12-21 |
EP2820017A4 (en) | 2015-08-05 |
CA2865517A1 (en) | 2013-09-06 |
JP2015508785A (en) | 2015-03-23 |
CN104507936A (en) | 2015-04-08 |
US20150175621A1 (en) | 2015-06-25 |
EP2820017A1 (en) | 2015-01-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG11201405055TA (en) | Pyridinyl and pyrimidinyl sulfoxide and sulfone derivatives | |
HK1209109A1 (en) | Pyridinone and pyridazinone derivatives | |
SG10201701894SA (en) | Amido-Benzyl Sulfone and Sulfoxide Derivatives | |
HK1245256B (en) | Pyridinyl and fused pyridinyl triazolone derivatives | |
IL239261A0 (en) | Lipocalin fusion partners | |
EP2828258A4 (en) | Novelpyridopyrimidine derivatives and use thereof | |
EP2885318A4 (en) | Peptide-dendrimer conjugates and uses thereof | |
HK1209107A1 (en) | Aminoquinazoline and pyridopyrimidine derivatives | |
EP2884135A4 (en) | Thermoregulator and thermoregulator component | |
ZA201503765B (en) | Wing and application thereof | |
PT2822936T (en) | Aminoquinoline derivatives and uses thereof | |
EP2964625A4 (en) | Quinoline sulfonyl derivatives and uses thereof | |
ZA201503367B (en) | Heteroaryl derivatives and uses thereof | |
EP2907282A4 (en) | Initialization and tracking for low power link states | |
HK1198833A1 (en) | N-acylpeptide derivatives and their uses n- | |
EP2836764A4 (en) | Swivelling joint | |
EP2817004A4 (en) | Bouvardin derivatives and therapeutic uses thereof | |
GB201214878D0 (en) | Joint configuration | |
IL232896A0 (en) | Fungicidal n-bicycloalkyl and n-tricycloalkyl pyrazole-4-(thio) crboxamide derivatives | |
GB201315005D0 (en) | Pivotal joint comprising first and second frames | |
GB201207119D0 (en) | Hamason hinges | |
AU2012901434A0 (en) | Swivelling joint |